• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Dupuytren's disease treatment during the second wave of COVID-19 pandemic.新冠疫情第二波期间的掌腱膜挛缩症治疗
J Plast Reconstr Aesthet Surg. 2021 Mar;74(3):644-710. doi: 10.1016/j.bjps.2020.12.030. Epub 2020 Dec 24.
2
Percutaneous needle fasciotomy for Dupuytren's disease: A one-stop approach incidentally suited to the era of COVID-19.经皮针状筋膜切开术治疗掌腱膜挛缩症：一种适用于 COVID-19 时代的一站式方法。
J Plast Reconstr Aesthet Surg. 2020 Nov;73(11):2086-2102. doi: 10.1016/j.bjps.2020.08.037. Epub 2020 Aug 29.
3
Reply to letter regarding "Percutaneous needle fasciotomy for Dupuytren's disease: A one-stop approach incidentally suited to the era of COVID-19".关于“经皮针状筋膜切开术治疗掌腱膜挛缩症：一种适用于COVID-19时代的一站式方法”的信件回复
J Plast Reconstr Aesthet Surg. 2021 Jul;74(7):1633-1701. doi: 10.1016/j.bjps.2021.01.018. Epub 2021 Feb 10.
4
Regression of Dupuytren's contracture.掌腱膜挛缩的消退
J Hand Surg Br. 1992 Aug;17(4):453-7. doi: 10.1016/s0266-7681(05)80273-6.
5
Three-year recurrence of Dupuytren's contracture after needle fasciotomy and collagenase injection: a two-centre randomized controlled trial.针刀筋膜切开术和胶原酶注射治疗掌腱膜挛缩症三年后的复发情况：一项双中心随机对照试验
J Hand Surg Eur Vol. 2018 Oct;43(8):836-840. doi: 10.1177/1753193418786947. Epub 2018 Jul 17.
6
One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: A two-centre prospective randomized clinical trial.针式筋膜切开术与胶原酶注射治疗掌腱膜挛缩症的一年期结果：一项双中心前瞻性随机临床试验
J Hand Surg Eur Vol. 2016 Jul;41(6):577-82. doi: 10.1177/1753193415617385. Epub 2015 Dec 1.
7
Nonoperative treatment of Dupuytren's disease.掌腱膜挛缩症的非手术治疗
Hand Clin. 1999 Feb;15(1):97-107, vii.
8
Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.掌腱膜挛缩症管理的成本效益。加拿大当前和未来管理策略的成本效益分析。
Bone Joint J. 2013 Aug;95-B(8):1094-100. doi: 10.1302/0301-620X.95B8.31822.
9
Dupuytren's Contracture: An Evidence Based Review.掌腱膜挛缩症：基于证据的综述
Ann Plast Surg. 2018 Dec;81(6S Suppl 1):S97-S101. doi: 10.1097/SAP.0000000000001607.
10
Needle fasciotomy for Dupuytren's contracture- a prospective cohort study of 58 fingers with a median follow-up of 6.5 years.针刀治疗掌腱膜挛缩症- 58 指前瞻性队列研究，中位随访 6.5 年。
J Plast Surg Hand Surg. 2020 Apr;54(2):89-93. doi: 10.1080/2000656X.2019.1693391. Epub 2019 Nov 22.

引用本文的文献

1
Reply to letter regarding "Percutaneous needle fasciotomy for Dupuytren's disease: A one-stop approach incidentally suited to the era of COVID-19".关于“经皮针状筋膜切开术治疗掌腱膜挛缩症：一种适用于COVID-19时代的一站式方法”的信件回复
J Plast Reconstr Aesthet Surg. 2021 Jul;74(7):1633-1701. doi: 10.1016/j.bjps.2021.01.018. Epub 2021 Feb 10.

Dupuytren's disease treatment during the second wave of COVID-19 pandemic.

作者信息

Cilli Vitale

机构信息

Centre Hospitalier Interregional Edith Cavell, Bruxelles, Belgium.

出版信息

J Plast Reconstr Aesthet Surg. 2021 Mar;74(3):644-710. doi: 10.1016/j.bjps.2020.12.030. Epub 2020 Dec 24.

DOI:10.1016/j.bjps.2020.12.030
PMID:33390345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834312/
Abstract
摘要